NCT06358248 Standardized Physician-modified Fenestrated Endograft Registry
| NCT ID | NCT06358248 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Padova |
| Condition | Aortic Aneurysm, Thoracoabdominal |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2028-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-10-01 with a primary completion date of 2028-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter retrospective study including all consecutive patients treated by PMEG using a standard modification technique of Valiant Captivia (Medtronic, Minneapolis, MN-USA).
Eligibility Criteria
INCLUSION CRITERIA * Complex AAA (including short-neck AAA, JRAA, PRAA, extent IV TAAA) * Haemodynamic stability * Anatomical feasibility is based on the presence of a proximal aortic neck above the mid celiac trunk of ≥25 mm in length and between 18 mm and 35 mm in diameter; the neck needs to be "healthy" with no parietal calcifications or thrombus with a cylindrical shape. The visceral aorta is required to be no larger than 40 mm in maximum diameter. EXCLUSION CRITERIA * Extent I-III TAAA * Hemorrhagic shock
Contact & Investigator
Michele Piazza, MD
PRINCIPAL INVESTIGATOR
University Hospital Padova
Frequently Asked Questions
Who can join the NCT06358248 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Aortic Aneurysm, Thoracoabdominal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06358248 currently recruiting?
Yes, NCT06358248 is actively recruiting participants. Contact the research team at michele.piazza@unipd.it for enrollment information.
Where is the NCT06358248 trial being conducted?
This trial is being conducted at Padova, Italy.
Who is sponsoring the NCT06358248 clinical trial?
NCT06358248 is sponsored by University Hospital Padova. The principal investigator is Michele Piazza, MD at University Hospital Padova. The trial plans to enroll 50 participants.